Universal Health International Group Holding Limited (2211.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Universal Health International Group Holding Limited
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
1198
First IPO Date
December 12, 2013
Key Executives
| Name | Title | Pay | Year Born |
| Chuanfu Chu | Chief Executive Officer, Chief Operating Officer & Executive Chairman | 577,606 | 1970 |
| Zehua Zhao | GM of Finance & Executive Director | 549,825 | 1968 |
| Dongkun Jin | Vice President & Executive Vice Chairman | 583,394 | 1973 |
| Kit Ying Hui | Company Secretary | 0 | N/A |
Description
Operating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern region. Its extensive offerings span both Western and traditional Chinese medicines, including patent medicines, chemical preparations, antibiotics, biochemical and biological drugs, traditional Chinese medicine decoction pieces, protein assimilation preparations, peptide hormones, and blood products. The company also supplies medical equipment, disinfection products, nutritional and prepackaged foods, health care items, cosmetics, daily necessities, and specific consumer goods such as family planning supplies (e.g., contraceptives) and infant formula milk powder. Furthermore, Universal Health International Group Holding Limited provides storage services to its varied clientele, which includes pharmaceutical retailers, hospitals, clinics, and distributors. Founded in 1998, the enterprise was formerly known as Jintian Pharmaceutical Group Limited until its rebranding in July 2015, and its corporate headquarters are located in Shenyang, People's Republic of China.